Skip to content

Clinical trials

Phase 3 Dengue trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dengue Phase: Phase 3 Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20102
20114
20165
20171
20182
20192
20211
20231
20241
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Unknown status4
Active, not recruiting2
Not yet recruiting2
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda9
Sanofi Pasteur, a Sanofi Company8
Butantan Institute3
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh1
Indonesia University1
Innogene Kalbiotech Pte. Ltd1
Khyber Medical University Peshawar1
London School of Hygiene and Tropical Medicine1
Oxford University Clinical Research Unit, Vietnam1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dengue27
Severe Dengue12
Flavivirus Infections2
Arbovirus Infections1
Chikungunya Fever1
Encephalitis, Japanese1
Hemorrhage1
Hemorrhagic Fevers, Viral1
Malaria1
Mosquito-Borne Diseases1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.